VRAX: financial statements from SEC

Income statement

Metric	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue	6,331	156,419	8,561	0
Cost of revenue	59,398	105,829	9,926	—
Gross profit	−53,067	50,590	−1,365	—
Research and development	2m	2m	2m	433,743
Selling, general and administrative	4m	5m	4m	1m
Operating income	−6m	−6m	−6m	−2m
Pre-tax income	−6m	−7m	−5m	−2m
Income tax	−136,661	—	—	—
Net income	−6m	−7m	−5m	−2m
Earnings per share	−1.62	−3.36	−5.13	−1.79
Earnings per share, diluted	−1.62	−3.36	−5.13	−1.79
Weighted average shares	4m	2m	1m	956,326

Metric	Aug 18, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash and equivalents	—	4m	4m	9m	21,756	17,621
Inventory	—	94,675	60,383	0	—	—
Current assets	—	5m	4m	10m	—	—
Property, plant and equipment	—	1m	897,627	—	—	—
Total assets	—	6m	5m	10m	—	—
Current liabilities	—	673,207	168,849	908,401	—	—
Total liabilities	—	964,750	345,194	908,401	—	—
Equity	—	5m	5m	9m	−1m	−831,814
Shares outstanding	—	4m	3m	2m	—	—
Shares issued	—	4m	3m	2m	—	—

Metric	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating cash flow	−5m	−6m	−4m	−809,070
Depreciation and amortisation	266,601	54,870	—	—
Share-based compensation	365,309	1m	2m	—
Capital expenditure	603,890	952,497	—	—
Investing cash flow	−603,890	−1m	−178,403	—
Financing cash flow	6m	2m	14m	813,205